关注
Nadège Dubois
Nadège Dubois
在 student.ulg.ac.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
IκBζ: an emerging player in cancer
M Willems, N Dubois, L Musumeci, V Bours, PA Robe
Oncotarget 7 (40), 66310, 2016
572016
Constitutive activation of casein kinase 2 in glioblastomas: absence of class restriction and broad therapeutic potential
N Dubois, M Willems, MT Nguyen-Khac, J Kroonen, N Goffart, M Deprez, ...
International Journal of Oncology 48 (6), 2445-2452, 2016
212016
“Debriefing and Organizational Lessons Learned”(DOLL): a qualitative study to develop a classification framework for reporting clinical debriefing results
M Paquay, N Dubois, AN Diep, G Graas, T Sassel, J Piazza, JC Servotte, ...
Frontiers in Medicine 9, 882326, 2022
122022
Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region
N Dubois, A Nguyet Diep, A Ghuysen, J Declaye, AF Donneau, G Vogin, ...
BMC Medical Education 22 (1), 485, 2022
92022
Exploring the feasibility of the Magnet Hospital concept within a European university nursing department: a mixed-methods study
M Paquay, JM Boulanger, M Locquet, N Dubois, A Ghuysen
Contemporary nurse 57 (3-4), 187-201, 2021
72021
The COVID-19 status of patients is an essential determinant for decision-making by radiation oncologists: a European survey
SB Mustapha, P Simoni, N Dubois, N Jansen, F Lakosi, AS Mota, ...
Cureus 14 (3), 2022
32022
STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
N Dubois, S Berendsen, K Tan, L Schoysmans, W Spliet, T Seute, V Bours, ...
International Journal of Oncology 61 (4), 1-9, 2022
22022
I-Kappa-B kinase-epsilon activates nuclear factor-kappa B and STAT5B and supports glioblastoma growth but amlexanox shows little therapeutic potential in these tumors
N Dubois, S Berendsen, A Henry, M Nguyen, V Bours, P Robe
Cancer Translational Medicine 4 (1), 2018
22018
CS-36 IkappaB ZETA OVEREXPRESSION DRIVES HUMAN GLIOMA RESISTANCE TO NECROPTOSIS
M Willems, J Kroonen, N Dubois, S Berendsen, B Nguyen, M Bredel, ...
Neuro-oncology 16 (suppl_5), v58-v59, 2014
12014
Impact of virtual reality training in disaster medicine
S Chevalier, N Dubois
Archives of Public Health, 2021
2021
Simulation-based training development to strive for excellence in radiation oncologist's education
N DUBOIS, S CUCCHIARO, S BEN MUSTAPHA, M NOEL, ...
2019
Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance
N Dubois, M Willems, J Kroonen, S Berendsen, W Van Hecke, M Bredel, ...
28th EORTC-NCI-AACR symposium on" Molecular targets and cancer therapeutics", 2016
2016
Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment
R Karim, C Pallazo, N Dubois, V Bours, C Passirani-Malleret, B Evrard, ...
4th Congress on Innovation in Drug Delivery Site-Specific Drug Delivery, 2016
2016
Involvement of Iκbζ in glioblastomas and its potential implication in radioresistance
N Dubois, M Willems, J Kroonen, S Berendsen, W Van Hecke, M Bredel, ...
European Journal of Cancer 1 (69), S21, 2016
2016
Stealth Liposome and Drug-In-Cyclodextrin-In-Liposome Formulations Entrapping Apigenin as Novel Therapy for Glioblastoma
R Karim, C Palazzo, N Dubois, V Bours, C Passirani, B Evrard, G Piel
'From drug development to target drug'-UniGR workshop on Biomedicine, 2015
2015
Liposomes entrapping apigenin for the treatment of glioblastoma
R Karim, C Palazzo, N Dubois, V Bours, C Passirani, G Piel
2015 UKICRS Workshop & Symposium, 2015
2015
PEGylated liposomes containing apigenin for the treatment of glioblastoma
R Karim, C Palazzo, N Dubois, V Bours, C Passirani, G Piel
1st European conference on Pharmaceutics Reims 2015, 2015
2015
Design of Liposomes Entrapping Apigenin-A Novel Approach for Glioblastoma Therapy
R Karim, C Palazzo, N Dubois, A Frère, V Bours, C Passirani, B Evrard, ...
2015 AAPS Annual Meeting and Exposition, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–18